menu search

Veru reaches agreement with fda on new phase 3 clinical trial for sabizabulin for broader indication: hospitalized adult patients with any type of viral acute respiratory distress syndrome (ards)

–Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population to include all hospitalized adult patients with a...

September 26, 2023, 12:30 pm

Veru reports fiscal 2023 second quarter financial results

Agreement reached with FDA on confirmatory Phase 3 clinical trial design for sabizabulin treatment of h...

May 11, 2023, 10:30 am

Why is veru (veru) stock down 37% today?

Veru (NASDAQ: VERU ) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment. That rejection...

March 3, 2023, 9:23 am

Veru inc.: q1 revenues fall short and uncertainty looms, making it risky

Veru Inc. is eyeing emergency use authorization for its COVID-19 drug sabizabulin, which is currently u...

February 27, 2023, 1:33 pm

Valeo pharma says health canada has accepted for review veru's new drug submission for sabizabulin

Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said that Health Canada has accepted for review Veru's New Drug Submission (NDS-CV) for ...

January 26, 2023, 8:00 am

Veru provides update on fda advisory committee meeting regarding emergency use authorization of sabizabulin to treat hospitalized covid-19 patients at high risk for acute respiratory distress syndrome

MIAMI, FL, Nov. 09, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19...

November 10, 2022, 1:55 am

Veru stock soars 40% despite uncertainty surrounding covid-19 drug

Pharmaceutical firm Veru (NASDAQ: VERU ) kicked off the first complete week of November with a bang as it delivered overall positive results regarding...

November 7, 2022, 2:30 pm

Veru inc.: a very complicated tale

Today, we put Veru Inc. in the spotlight for the first time. The stock fell over 20% trading Wednesday after the FDA stated it would require an AdComm...

September 8, 2022, 12:49 pm

Veru announces date for fda advisory committee meeting to review emergency use authorization for sabizabulin for hospitalized covid-19 patients at high risk for acute respiratory distress syndrome

—Advisory Committee Meeting Scheduled for October 06, 2022— —Advisory Committee Meeting Scheduled for October 06, 2022—...

September 7, 2022, 1:45 pm

Veru: the signs seem to point to an eua for sabizabulin

Veru ought to find out very soon whether its lead asset, sabizabulin, has been awarded an Emergency Use...

July 13, 2022, 12:04 pm

Veru: on right track for fda eua submission

An Emergency Use Authorization submission of sabizabulin for high-risk hospitalized Covid-19 patients i...

May 27, 2022, 3:45 pm

Veru inc. still has serious growth to realize

Veru Inc is a Florida-based drug developer, which focuses primarily on developing cancer-treatment drugs as well as its sexual health division. This y...

May 19, 2022, 3:41 am

Veru's stock nearly triples as covid-19 drugs cuts reduces deaths by 55% in hospitalized patients

Veru Inc (NASDAQ: VERU) has announced positive efficacy and safety results from a planned interim analysis of Phase 3 COVID-19 trial evaluating ora...

April 11, 2022, 12:10 pm

Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19

The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disrup...

January 31, 2022, 11:41 am

Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19

The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disrup...

January 31, 2022, 11:41 am

Veru's cancer candidate sabizabulin gets fda fast track tag for covid-19

The FDA has granted Fast Track designation to Veru Inc's VERU sabizabulin, oral cytoskeleton disrup...

January 31, 2022, 11:41 am


Search within

Pages Search Results: